Source: Pharmacogenomics and Personalized Medicine. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, POLIMORFISMO, BRASILEIROS, PACIENTES
ABNT
SALGADO, Patricia de Cássia et al. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients. Pharmacogenomics and Personalized Medicine, v. 10, p. 101-106, 2017Tradução . . Disponível em: https://doi.org/10.2147/pgpm.s131390. Acesso em: 01 maio 2024.APA
Salgado, P. de C., Genvigir, F. D. V., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. Q., et al. (2017). Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients. Pharmacogenomics and Personalized Medicine, 10, 101-106. doi:10.2147/pgpm.s131390NLM
Salgado P de C, Genvigir FDV, Felipe CR, Silva Junior HT, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients [Internet]. Pharmacogenomics and Personalized Medicine. 2017 ; 10 101-106.[citado 2024 maio 01 ] Available from: https://doi.org/10.2147/pgpm.s131390Vancouver
Salgado P de C, Genvigir FDV, Felipe CR, Silva Junior HT, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients [Internet]. Pharmacogenomics and Personalized Medicine. 2017 ; 10 101-106.[citado 2024 maio 01 ] Available from: https://doi.org/10.2147/pgpm.s131390